An FDA-approved clinical trial is being conducted in the United States to collect additional data on ExAblate and the enhanced sonication technique, when treating up to 100% individual fibroid volume. This study is being conducted according to the current US commercial labeling and treatment guidelines.
If you would like to participate in the trial please contact one of the following treatment locations:
United States, Georgia
Atlanta Interventional Institute (Not yet recruiting)
Smyrna, Georgia, United States, 30080
Contact: Margie Mancao 770-801-4694 Margie.mancao@ahss.org
Principal Investigator: John Lipman, MD
United States, Michigan
Borgess Research Institute (recruiting)
Kalamazoo, Michigan, United States, 49048
Contact: Debbi Hotchkiss
Telephone: 269-226-8169
debbihotchkiss@borgess.com
Principal Investigator: Mark Shaman, MD
United States, North Carolina
Duke University (Not yet recruiting)
Durham, North Carolina, United States, 27705
Contact: Kristen A. Lynam, BA, RN Telephone: 919-668-7467
kristen.lynam@duke.edu
Principal Investigator: Haywood Brown, MD
United States, Virginia
University of Virginia Health System
Charlottesville, VA 22908
Contact: Sandra Burks, Telephone: 434-243-0315
Email: sgb2c@virginia.edu
Principal Investigator: Alan Matsumoto, MD
United States, California
UCSD Department of Radiology
San Diego, CA, United States
Contact: Bob Halterman, CCRC
Telephone: 619-543-5830
Email: rhalterman@ucsd.edu
Principal Investigator: Anne Roberts, MD
Click here for additional information on eligibility requirements:
RSS | Contact Us | 
| Hebrew site